Heat Biologics

Launch date

2008

Employees

Market cap

Net debt

-

Enterprise valuation

$6m (Public information from Apr 2024)

Chapel Hill North Carolina (HQ)

http://heatbio.com

https://twitter.com/heatbiologics https://www.facebook.com/pages/heat-biologics/274527565934266 https://www.linkedin.com/company/heat-biologics

Deals in current and previous year:

Elusys Therapeutics

Revenues, earnings & profits over time

USD	2019	2020	2021	2022	2023	2024	2025
Revenues	0000	0000	0000	0000	0000	0000	0000
% growth	(50 %)	-	(33 %)	200 %	17 %	194 %	70 %
EBITDA	0000	0000	0000	0000	0000	0000	0000
Profit	0000	0000	0000	0000	0000	0000	0000
% profit margin	(667 %)	(867 %)	(1750 %)	(717 %)	(646 %)	(108 %)	(47 %)
EV / revenue	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x
EV / EBITDA	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x
R&D budget	0000	0000	0000	0000	0000	0000	0000

Get premium to view all results

Date	Investors	Amount	Round
-	investor	$0.0	round
Jul 2013	N/A	$0.0	round
Aug 2014	investor	$0.0	round
May 2018	N/A	$0.0	round
Nov 2018	N/A	$0.0	round
Jan 2020	N/A	$0.0	round
Dec 2023*	N/A	$2.3m	Post IPO Debt
Total Funding		000k

Tech stackLearn more about the technologies and tools that this company uses.

Elusys Therapeutics

ACQUISITION by Heat Biologics Apr 2022